Tavegil

Medicinal product

(Invented) name

Tavegil

Active substance (s)

Klemastinas

Strength

2 mg/2 ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną, leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R06AA04, Clemastine

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-12-23

Date of renewal

Documents

3105_Tavegil_2 mg2 ml_PZ.docx

3105_Tavegil_2 mg2 ml_PL.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

2 ml tirpalo yra	2 ml
Klemastinas	2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119513	105619	1105619	ampulė	2 ml N5		Receptinis	LT/L/25/3105/001	Netiekiama	-	2026-02-23	No	-	-	Download

Stadijos

Data	Stadija
2025-12-23	Registruotas